Comirnaty, Pfizer’s COVID-19 prevention vaccine, reported global sales of $1.15 billion
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
Subscribe To Our Newsletter & Stay Updated